Radnostix, Inc. (INIS)
Oxford Ledge is still expanding full research coverage of INIS. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
Radnostix manufactures radioisotope products for medical and industrial use across five business segments including theranostics, cobalt, calibration reference products, medical devices, and fluorine products.
SEC filings
- 8-K Entry into material agreement; Completion of acquisition or disposition; Creation of direct financial obligation; 3.02; Financial statements and exhibits 2026-07-01
- DEF 14A Proxy statement for shareholder vote 2026-06-04
- 8-K 3.03; Amendments to articles or bylaws; Financial statements and exhibits 2026-05-20
- 10-Q Quarterly financial report (unaudited) 2026-05-20
- 10-K/A Amended annual report 2026-04-30
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for INIS. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open INIS in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.